Delivering orphan drugs to rare disease patients

September 24, 2024 | Press Release

Announcement of Marketing Authorization Transfer for Rabipur Intramuscular Injection

July 03, 2023 |

Updated Who we are

April 13, 2023 | Press Release

Announcement for Initiation of Phase III Trial of Glycerol Phenylbutyrate in Urea Cycle Disorders in Japan

January 13, 2023 |

Updated organization chart

May 23, 2022 |

Announcement of exclusive license agreement for development, manufacturing and sale of glycerol phenylbutyrate in Japan